Category: SPMS-PPMS News

Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial

Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS 02/17/26 Roche has reported late-breaking phase 3 data…

Stuart Schlossman

CONNECT with Our MS Community Chat

Connect to a Forum for MS “lived” experiences From anywhere, interface with People who understand MS. Join us so you…

Stuart Schlossman

video: Moderated & Public Q&A with MS Neurologists Boster and LaGanke

Event date: July 26, 2025 Moderator: Stuart Schlossman, President of MS Views and News / MS Patient Advocate At the…

Stuart Schlossman

Featured image for “Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis”

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Paris, April 8, 2025. The New…

Stuart Schlossman

What to Know About Multiple Sclerosis Progression in Chart Form

A more visual explanation of the progression of MS can be helpful for understanding your symptoms and the type of…

Stuart Schlossman

Featured image for “video: What is MS? Everything You Need to Know!”

video: What is MS? Everything You Need to Know!

Welcome to Aaron Boster MD, your trusted source for understanding Multiple Sclerosis (MS). * In this video, we dive deep…

Stuart Schlossman

Featured image for “International Workshop Focuses on Aging with Multiple Sclerosis”

International Workshop Focuses on Aging with Multiple Sclerosis

May 28, 2024 Almost half of all people living with MS today are 55 years of age or older, and…

Stuart Schlossman

Reasons Patients With Primary Progressive Multiple Sclerosis Contact Their Specialist Nurses

 Jacquelyn Bainbridge, PharmD; Rebecca Barnhart, PharmD; Ryan Fuller, PharmD; Van T. Hellerslia, PharmD; Julie Kidd, PharmD; Steven Merrill, PharmD; Emily…

Stuart Schlossman

Primary progressive MS confirmed as own disorder in mouse study

 Antibodies in spinal fluid seen to drive PPMS, but not relapsing MS by Marisa Wexler, MS | February 7, 2023…

Stuart Schlossman

Primary progressive MS confirmed as own disorder in mouse study

 by Marisa Wexler, MS | February 7, 2023 Antibodies in spinal fluid seen to drive PPMS, but not relapsing MS…

Stuart Schlossman

Categories

Latest Blog Posts